Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.45 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.45 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | ESR1 | P03372 | 3/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL27959903 | 0.94 | ERN1 (0.42) | ERN1TLR2TLR1TLR6ALDH1A1 | |
| SCHEMBL17508181 | 0.84 | KMT2A (0.46) | ALDH1A1ESR1ESR2CYP3A4TRIM24 | |
| SCHEMBL7138544 | 0.83 | ERN1 (0.50) | ERN1TLR2TLR1TLR6ALDH1A1 | |
| SCHEMBL1276539 | 0.82 | CA2 (0.56) | ALDH1A1ESR1ESR2CYP3A4KMT2A | |
| SCHEMBL30829189 | 0.81 | ESR1 (0.44) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL3241119 | 0.81 | ESR1 (0.44) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL31587806 | 0.80 | ALOX12 (0.62) | ERN1TLR2TLR1TLR6ALDH1A1 | |
| SCHEMBL173039 | 0.80 | ALOX12 (0.62) | ERN1TLR2TLR1TLR6ALDH1A1 | |
| SCHEMBL1685305 | 0.80 | ERN1 (0.53) | ERN1ALDH1A1ESR1ESR2CYP3A4 | |
| SCHEMBL15771550 | 0.80 | ALOX5 (0.48) | ERN1ALDH1A1ESR1ESR2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2174928-B1 | TRANSITION METAL COMPLEX COMPOUND, OLEFIN OLIGOMERIZATION CATALYST CONTAINING THE COMPOUND, AND METHOD FOR PRODUCING OLEFIN OLIGOMER PERFORMED IN THE PRESENCE OF THE CATALYST | MITSUI CHEMICALS INC (JP) | 2015-03-11 | — | — | EP | disclosed |
| US-8258361-B2 | Transition metal complex compounds, olefin oligomerization catalysts including the compounds, and processes for producing olefin oligomers using the catalysts | MITSUI CHEMICALS, INC. (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20110082325-A1 | TRANSITION METAL COMPLEX COMPOUNDS, OLEFIN OLIGOMERIZATION CATALYSTS INCLUDING THE COMPOUNDS, AND PROCESSES FOR PRODUCING OLEFIN OLIGOMERS USING THE CATALYSTS | MITSUI CHEMICALS, INC. | 2011-04-07 | — | — | US | disclosed |
| EP-2174928-A1 | TRANSITION METAL COMPLEX COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE COMPOUND, AND METHOD FOR PRODUCING OLEFIN POLYMER PERFORMED IN THE PRESENCE OF THE CATALYST | Mitsui Chemicals, Inc. (JP) | 2010-04-14 | — | — | EP | disclosed |
| CN-101687776-A | Transition metal complex compound, olefin polymerization catalyst containing the compound, and method for producing olefin polymer performed in the presence of the catalyst | MITSUI CHEMICALS INC | 2010-03-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082325-A1 | TRANSITION METAL COMPLEX COMPOUNDS, OLEFIN OLIGOMERIZATION CATALYSTS INCLUDING THE COMPOUNDS, AND PROCESSES FOR PRODUCING OLEFIN OLIGOMERS USING THE CATALYSTS | OSTC, COG4, COG7 | ERN1 2069/4885TLR2 3811/4885TLR1 3009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.